Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › IONS

DEERFIELD MANAGEMENT COMPANY, L.P. position in IONS

IONIS PHARMACEUTICALS INC · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 60,000,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$93.1M, representing 1.17% of its reported portfolio and ranking #26 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed IONS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)60.00M sh
Reported value held$93.10M
Portfolio Weight1.17%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s IONS position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in IONS in Q3 2025 at 60,000,000 shares (US$82.7M). The position peaked in Q4 2025 at 60,000,000 shares, worth US$95.3M. Across 4 filings, DEERFIELD MANAGEMENT COMPANY, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 60,000,000 shares valued at US$93.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 60.00M $82.66M New
Q4 2025 60.00M $95.33M Hold
Q1 2026 60.00M $90.61M Hold
Q2 2026 60.00M $93.10M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held IONS?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed IONS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in IONS?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 60.00M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $93.10M, representing 1.17% of its reported portfolio and ranking #26.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling IONS?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in IONS. The position peaked in Q4 2025 at 60.00M shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.